GNAT3抗体;GNAT3 Antibody—艾普蒂

+ +

•  

   

     Gel: 8%SDS-PAGE, Lysate: 40 μg, Lane 1-2: Mouse heart tissue, Mouse muscle tissue, Primary antibody: P11796(GNAT3 Antibody) at dilution 1/400, Secondary antibody: Goat anti rabbit IgG at 1/8000 dilution, Exposure time: 1 minute    

  
  

•  

   

     The image is immunohistochemistry of paraffin-embedded Human thyroid cancer tissue using P11796(GNAT3 Antibody) at dilution 1/35. (Original magnification: ×200)    

  
  

•  

   

     The image is immunohistochemistry of paraffin-embedded Human esophagus cancer tissue using P11796(GNAT3 Antibody) at dilution 1/35. (Original magnification: ×200)    

  
  

**Background of GNAT3 Antibody**

GNAT3 (Guanine Nucleotide-Binding Protein G(t) Subunit Alpha-3), also known as gustducin α, is a G-protein α-subunit critical in signal transduction pathways linked to taste perception and metabolic regulation. It is primarily expressed in taste receptor cells, where it couples with bitter, sweet, and umami taste receptors to mediate intracellular signaling via cyclic nucleotide or phosphoinositide pathways. GNAT3 forms part of the gustducin heterotrimer (with βγ subunits), which activates downstream effectors like phospholipase C-β2 (PLCβ2) or phosphodiesterases, ultimately triggering neurotransmitter release and taste signal transmission to the brain.

GNAT3 antibodies are essential tools for studying taste biology, as they enable the detection and localization of GNAT3 in tissues. These antibodies are widely used in techniques such as Western blotting, immunohistochemistry, and immunofluorescence to explore GNAT3 expression patterns in taste buds, as well as its unexpected roles in non-gustatory tissues (e.g., gut, pancreas), suggesting broader functions in nutrient sensing and metabolism. Research involving GNAT3 antibodies has contributed to understanding taste dysfunction, obesity, and diabetes, as GNAT3 is implicated in regulating energy homeostasis. Additionally, studies highlight its potential interaction with extraoral receptors influencing metabolic diseases, making GNAT3 a target for therapeutic strategies targeting taste-related or metabolic disorders.